Sonoma Biotherapeutics Appoints Lisa Taylor Ash, as Chief Legal Officer
August 25, 2025
Sonoma Biotherapeutics, a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, announced the appointment of Lisa Taylor Ash,